Detalles de la búsqueda
1.
MDR1 single nucleotide polymorphism G2677T/A and haplotype are correlated with response to docetaxel-cisplatin chemotherapy in patients with non-small-cell lung cancer.
Respiration
; 78(1): 49-55, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-18812689
2.
MDR1 single nucleotide polymorphisms predict response to vinorelbine-based chemotherapy in patients with non-small cell lung cancer.
Respiration
; 75(4): 380-5, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-17851225
3.
[Preliminary study of biweekly regimen of docetaxel, oxaliplatin, 5-fluorouracil and leucovorin for advanced gastric cancer].
Zhonghua Zhong Liu Za Zhi
; 30(5): 389-91, 2008 May.
Artículo
en Zh
| MEDLINE | ID: mdl-18953843
4.
[A randomized phase II trial of docetaxel and doxorubicin in treatment for patients with non-small-cell lung cancer who have failed previous platinum-based chemotherapy].
Zhonghua Zhong Liu Za Zhi
; 30(6): 465-8, 2008 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-19024525
5.
[Docetaxel in the treatment of advanced breast cancer ].
Zhonghua Zhong Liu Za Zhi
; 28(6): 468-70, 2006 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-17152498
6.
CYP450 polymorphisms predict clinic outcomes to vinorelbine-based chemotherapy in patients with non-small-cell lung cancer.
Acta Oncol
; 46(3): 361-6, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17450472
Resultados
1 -
6
de 6
1
Próxima >
>>